Atuka sets a higher standard for neuroscientific expertise and rigor, providing unmatched translational drug development and chemistry services to identify and advance breakthrough neurotherapeutic candidates. We are deeply experienced in Parkinson’s disease and other movement-related disorders, as well as cognitive diseases. We also offer industry-leading rodent and non-human primate models.
At Atuka, we simply do better science. Explore our resources to learn more.
In collaboration with researchers in Wurzburg, Germany, Atuka co-authored a paper that further characterizes the AAV-A53T-aSyn rat model of Parkinson’s disease. Atuka extensively uses this model to evaluate potential therapies. Read the full paper.